P.0463 Phase 1 open-label study assessing the pharmacokinetics and safety of TV-46000, a novel long-acting subcutaneous injectable formulation of risperidone
| Autor: | Wagner, A. Merenlender, Elgart, A., Perlstein, I., Lamson, M., Tiver, R., Kalmanczhelyi, A., Spiegelstein, O., Mackellar, A., Harary, E. |
|---|---|
| Zdroj: | In European Neuropsychopharmacology December 2021 53 Supplement 1:S339-S340 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect